Elliot Wilbur analyst

Currently out of the existing stock ratings of Elliot Wilbur, 15 are a HOLD (12.71%), 103 are a BUY (87.29%).

Elliot Wilbur

Work Performance Price Targets & Ratings Chart

Analyst Elliot Wilbur, carries an average stock price target met ratio of 53.17% that have a potential upside of 38% achieved within 513 days. Previously, Elliot Wilbur worked at RAYMOND JAMES, NEEDHAM.

Elliot Wilbur’s has documented 219 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on SLGL, Sol Gel Technologies Ltd at 11-Aug-2023.

Wall Street Analyst Elliot Wilbur

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS) at 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%) receiving and performance score of 19.59.

Average potential price target upside

ADMP Adamis Pharma AGN Allergan plc AKRX Akorn ANIP ANI Pharmaceuticals ATRS Antares Pharma FLXN Flexion Therapeutics MNK Mallinckrodt plc MYL Viatris PLXP PLx Pharma PRGO Perrigo Company PLC PTX Pernix Therapeutics Holdings SGNT Sagent Pharmaceuticals SLGL Sol Gel Technologies Ltd TEVA Teva Pharma Industries Ltd ADR ADMA ADMA Biologics AMRX Amneal Pharmaceuticals CVET Covetrus PETQ PetIQ PYPD PolyPid VTRS Viatris ZTS Zoetis AERI Aerie Pharmaceuticals AMPH Amphastar P OGN Organon DERM Journey Medical Corp VRTS Virtus Investment Partners

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Jun-2020

4 years 5 months 12 days ago
(19-May-2022)

2/5 (40%)

$25.55 (57.48%)

136

Buy Since 16-Nov-2020

5 years 11 months 15 days ago
(16-Nov-2020)

0/3 (0%)

$1128.5 (658.02%)

Hold Since 26-Nov-2019

6 years 11 months 5 days ago
(26-Nov-2019)

1/1 (100%)

$-364 (-98.11%)

2030

Sell Since 23-Jul-2019

$77

7 years 3 months 8 days ago
(23-Jul-2019)

2/6 (33.33%)

$-12.6 (-14.06%)

9

$5

$4.51 (920.41%)

9 years 10 months 11 days ago
(20-Dec-2016)

1/1 (100%)

$-191 (-97.45%)

2327

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?